SiDx Appoints Dr. Caroline Popper to Board of Directors

Heritage Partners is honored to have played a role as the consultants to SiDx in the recruiting of Caroline Popper as a Board Member. SiDx is a Seattle based diagnostics firm pioneering a new rapid diagnostic platform based on silicon photonics.

Dr. Popper is President of Popper and Company, a consultancy she co-founded in 2003 offering strategy and transaction advisory services to healthcare and life science companies. She was a founder of Diversigen, a science-driven microbiome analysis company recently acquired by OraSure Technologies.  She is currently an Advisory Board member to the Johns Hopkins Bloomberg School of Public Health and to Riverside Partners, a private equity firm for healthcare and technology companies.  In addition to SiDx, Dr. Popper also serves as a Board Member to Avance Clinical, Agilex BioLabs, and LBT Innovations.

Dr. Popper’s early career included leadership roles with MDS Proteomics and BDGene, the molecular diagnostics division of Becton Dickinson. She earned a medical degree from University of Witwatersrand and a MPH from The Johns Hopkins University.

The recruiting effort was led by Alan Thomas, Partner with Heritage Partners.

Heritage Partners is a senior level retained executive search firm working in the life sciences and digital healthcare vertical. The firm’s strength is in providing executive leadership to emerging clients at the interface of science and business.